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Abstract
We consider the problem of optimal design of experiments for random effects models,
especially population models, where a small number of correlated observations can be taken
on each individual, while the observations corresponding to different individuals can be
assumed to be uncorrelated. We focus on c-optimal design problems and show that the
classical equivalence theorem and the famous geometric characterization of Elfving (1952)
from the case of uncorrelated data can be adapted to the problem of selecting optimal sets
of observations for the n individual patients. The theory is demonstrated in a linear model
with correlated observations and a nonlinear random effects population model, which is
commonly used in pharmacokinetics.
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1 Introduction
It is a common situation in pharmacokinetic trials that only a very small number of measure-
ments can be taken on a single patient, but a larger number of n different patients are available
[Schmelter (2007), Colombo et al. (2006)]. In this situation it is impossible to reliably estimate
parameters of interest for each patient. However, often these individual parameters are not of
primary interest, because it is assumed that the individual parameters are realizations of some
global distribution. Therefore, the main aim of the experiment is the estimation of the mean
and/or variance of this distribution. This results in a random effects model and is called the
population approach [Retout and Mentre´ (2003)]. Unfortunately, the common random effect
causes measurements an a single patient to be correlated, therefore most of the commonly used
tools of classical optimal design theory are not applicable in this context. Compared to the
uncorrelated case the optimal design problem for dependent data is intrinsically more difficult.
Most authors use asymptotic arguments to determine efficient designs [see Sacks and Ylvisaker
(1968), Bickel and Herzberg (1979), Na¨ther (1985), Dette et al. (2009), Mu¨ller and Pa´zman
(2003) among others]. In particular for the case of dependent data the powerful equivalence the-
orem [Pukelsheim (1993)] and geometric representations [Elfving (1952)] from the uncorrelated
case are not available.
In the present paper we try to fill this gap for the c-optimality criterion, which determines the
design such that the variance of a linear combination of the parameters (specified by the vector
c) is minimal. Note that many commonly used criteria (as designing the experiment for the
estimation of the area under the curve, the maximum concentration or, in dose finding studies,
the minimal effective dose) are special cases of the c-optimality criterion [see Atkinson et al.
(1993)]. In the following sections we show that if the number of available observations is the
same for each patient, the total information of all observations on a single patient, accounting for
correlations, can be expressed as a sum of information matrices in the usual form for uncorrelated
observations. More precisely, if m observations are available for each patient, there exist vector
valued functions f˜l, l = 1, ...,m(m + 1)/2 such that the total Fisher information matrix for the
set of m observations on this patient can be written in the form
I(θ) =
m(m+1)/2∑
l=1
ulf˜lf˜l
T
,(1.1)
where the quantities ul can take the values of −1, 0, 1 only. For this representation we introduce
in addition to the original design space for the individual observations a design space of m
observations for each patient. Using this representation, we can derive an equivalence theorem
for c-optimal designs using the general theory in Pukelsheim (1993) and apply recent results of
Dette and Holland-Letz (2009) to obtain a geometric characterization of c-optimal designs for
the problem of allocating the n available patients to different sets of m individual observations.
As a result we obtain a generalization of the famous result of Elfving to the case of dependent
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data.
The theoretical details are presented in Section 2. In Section 3 we demonstrate the application of
these ideas in two examples, a linear model and a basic nonlinear model taken from population
pharmacokinetics.
2 An Elfving representation for models with correlated
observations
We begin our discussion with the linear case where the results are slightly more transparent.
The nonlinear case can easily be reduced to this situation (see Remark 2.4), while the case of
random effect models is discussed in Section 3. Assume that m observations can be taken each
on a number of n individuals in the linear model
Yij = θ
Tf(xij) + ij; i = 1, ..., n, j = 1, ...,m,(2.1)
where Yij denotes the j−th observation on the i−th individual and xij is the experimental
condition corresponding to this observation, which is chosen from a compact interval X ⊂ R.
We use xi = (xi1, ..., xim) to denote all experimental conditions corresponding to the individ-
ual i. The vector θ = (θ1, ..., θk)
T ∈ Θ ⊂ Rk is the vector of parameters to be estimated,
f(x) = (f1(x), ..., fk(x))
T denotes a vector of known functions and ij a random error term with
expectation 0 and variance σ2j (j = 1, . . . ,m). Observations on the same individual are assumed
to be correlated, with corr(ij, ij∗) = c(xij, xij∗), while data corresponding to different individu-
als are assumed to be independent, i.e. corr(ij, i∗j) = 0, whenever i 6= i∗. We express the total
covariance matrix of errors as the block diagonal matrix V = diag(V1, . . . , Vn) ∈ (Rm×m)n, with
matrices
Vi = diag(σ1, ..., σm)(c(xir, xis))r,s=1,...,m diag(σ1, . . . , σm) ∈ Rm×m
on the diagonal. We now write Fi = (f(xi1), ..., f(xim)) ∈ Rk×m as the design matrix for
individual i, i = 1, ..., n, define the matrix F = (F1, . . . , Fn) = (f(x11), ..., f(xnm)) ∈ Rk×nm as
the design matrix corresponding to all patients, and denote by vlj(xi) the Element in the position
(l, j) of the matrix V −1i . The information matrix (inverse covariance matrix) of the weighted
least squares estimate for the parameter θ can be expressed as
M = FV −1F T =
n∑
i=1
FiV
−1
i F
T
i .(2.2)
The following arguments demonstrate that this expression can be rewritten in a form closer to
the usual form of information matrices, which is obtained in the case of uncorrelated obser-
vations. We begin with an alternative representation for the individual information matrices
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FiV
−1
i F
T
i , i = 1, ..., n. For this purpose we collect all experimental conditions corresponding
to one individual in a vector xi = (xi1, ..., xim) ∈ Rm and consider Xm as design space. An
exact design is characterized by a tuple (xi, ni)
n
i=1, where xi ∈ Xm and ni ∈ N such that∑p
i=1 ni = n. This means that ni of the n patients are treated under the experimental condition
xi = (xi1, ..., xim)
T (i = 1, ..., p). Our first result provides the information matrix corresponding
to one observation at the experimental condition xi.
Lemma 2.1 An information matrix of the form FiV
−1
i F
T
i can also be expressed as
FiV
−1
i F
T
i =
m(m+1)/2∑
l=1
ulf˜l(xi)f˜l(xi)
T ,(2.3)
where the functions f˜l : Xm → Rk and the constants ul ∈ {−1, 0, 1} are defined in equations
(2.7) and (2.8) below, respectively, l = 1, ...,m(m+ 1)/2.
Proof: Let V −1i = (vlj(xi))
m
l,j=1 denote the inverse of the matrix Vi, then a straightforward
calculation yields
FiV
−1
i F
T
i =
m∑
l=1
m∑
j=1
f(xil)f(xij)
Tvlj(xi)
=
m∑
l=1
m∑
j>l
[f(xil) + sgn(vlj(xi))f(xij)][f(xil) + sgn(vlj(xi))f(xij)]
T |vlj(xi)|
+
m∑
l=1
f(xil)f(xil)
T (vll(xi)−
m∑
j 6=l
|vlj(xi)|)
=
m∑
l=1
m∑
j>l
glj(xi)glj(xi)
T +
m∑
l=1
slhl(xi)hl(xi)
T ,
where the functions sl : Xm → {−1, 0, 1} and glj, hl : Xm → Rk are defined by
sl(xi) = sl(xi1, ..., xim) = sgn(vll(xi))−
m∑
j 6=l
|vlj(xi)|), l = 1, . . . ,m(2.4)
glj(xi) = glj(xi1, ..., xim) = (f(xil) + sgn(vlj(xi))f(xij))
√
|vlj(xi)|, l, j = 1, . . . ,m(2.5)
and
hl(xi) = hl(xi1, ..., xim) = f(xil)
√√√√|vll(xi)− m∑
j 6=l
|vlj(xi)||, l = 1, . . . ,m,(2.6)
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respectively. With the notation
f˜l =

hl if l = 1, ...,m
g1,l−m+1 if l = m+ 1, ..., 2m− 1
g2,l−2m+3 if l = 2m, ..., 3m− 3
...
...
gm−1,m if l = m(m+ 1)/2
(2.7)
and
ul =
{
sl if l = 1, ...,m
1 if l = m+ 1, ...,m(m+ 1)/2
(2.8)
we can express the information matrix as
FiV
−1
i F
T
i =
m(m+1)/2∑
l=1
ulf˜l(xi)f˜l(xi)
T ,(2.9)
which completes the proof of Lemma 2.1. 2
Using Lemma 2.1 the total information matrix for an exact design of m observations each on n
subjects can therefore be written as
M =
n∑
i=1
m(m+1)/2∑
l=1
ulf˜l(xi)f˜l(xi)
T .(2.10)
Following Kiefer (1974) we define an approximate design as a probability measure ξ on Xm with
finite support. Similarly to (2.10) the information matrix of an approximate design ξ using p
different sets of m single subject measurements (with weights ξ(xi) = ξ(xi1, ..., xim) at the points
xi) can be expressed as
M(ξ) =
p∑
i=1
m(m+1)/2∑
l=1
ulf˜l(xi)f˜l(xi)
T ξ(xi).(2.11)
If ξ puts masses ξi = ξ(xi) at points xi ∈ Xm (i = 1, ..., p,
∑p
i=1 ξi = 1) this means that approx-
imately ni ≈ nξi patients have to be treated under experimental conditions xi = (xi1, ..., xim)
(i = 1, ..., p). In practice the integers ni are obtained by an appropriate rounding procedure from
the quantities nξi [see for example Pukelsheim and Rieder (1992)]. Note that the design space
here is Xm, i.e. the space of all possible m-observation sets.
Recall that for a given vector c ∈ Rk an approximate design ξc is called c-optimal if and only
if c ∈ Range (M(ξc)) and ξc minimizes the expression cTM−(ξ)c, where M−(ξ) denotes the
generalized inverse of the matrix M(ξ) (note that this expression is approximately proportional
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to the variance of the weighted least squares estimate for the linear combination cT θ). We can
now use the representation (2.11) to derive a condition, which can be used to check the optimality
of a given approximate design. In the special case of c-optimal designs, i.e. designs which are
optimal for the estimation of a linear combination cT θ of the parameters (c ∈ Rk), we obtain the
following result.
Theorem 2.1. A design ξc is c-optimal in a regression model with information matrix of the
form (2.11) if and only if there exists a generalized inverse G of the matrix M(ξc) such that the
inequality
(2.12)
m(m+1)/2∑
`=1
u`
(
cTGf˜`(x)
)2
cTM−(ξc, θ)c
≤ 1
holds for all x ∈ Xm. Moreover, there is equality in (2.12) at any support point of the design ξc.
Proof of Theorem 2.1. Let Ξ denote the set of all approximative designs on Xm and let
M = {M(ξ) | ξ ∈ Ξ} ⊂ Rk×k
denote the set of all information matrices of the form (2.11). M is obviously convex and the
information matrix M(ξc) of a locally c-optimal design for which the linear combination c
T θ is
estimable [i.e. c ∈ Range (M(ξ))] maximizes the function (cTM−c)−1 in the set M∩Ac, where
Ac = {M(ξ)) ∈M | c ∈ Range(M(ξ))}.
Consequently it follows from Theorem 7.19 in Pukelsheim (1993) that the design ξc is c-optimal if
and only if there exists a generalized inverse, say G, of the matrix M(ξc) such that the inequality
tr(AGccTGT ) ≤ cTM−(ξc)c
holds for all A ∈M, where there is equality for any matrix A ∈M which maximizes (cTM−c)−1
in the set M. Note that the family M is the convex hull of the set
m(m+1)/2∑
`=1
u`f˜`(x)f˜
T
` (x)
∣∣∣∣x ∈ Xm
 ,
and therefore the assertion of Theorem 2.1 follows by a standard argument of optimal design
theory [see e.g. Silvey (1980)]. 2
If it can be shown that u` ≥ 0 for all ` = 1, ...,m(m + 1)/2 we can use this theorem to apply
Theorem 3.3 of Dette and Holland-Letz (2009) and derive a geometric characterization of c-
optimal designs for models with information matrices of the form (2.11), which generalizes the
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classical result of Elfving (1952) to the case of dependent data. For this purpose we define a
generalized Elfving set by
R(m(m+1)/2) = conv

m(m+1)/2∑
`=1
ε`f˜`(xθ)
∣∣∣∣ x ∈ Xm; m(m+1)/2∑
`=1
ε2` = 1
(2.13)
[note that the set R(m(m+1)/2) reduces for m = 1 to the classical Elfving space considered by
Elfving (1952)]. Additionally, we assume that the quantities u` defined in (2.8) are nonnegative
for all ` = 1 . . .m(m+ 1)/2, i.e.
vll(xi)−
m∑
j 6=l
|vlj(xi)| ≥ 0, l = 1, . . . ,m, i = 1, . . . , n.(2.14)
Theorem 2.2 Assume that (2.14) is satisfied. A design ξc = {xr, pr}pr=1 is locally c-optimal in
a model with information matrix of the form (2.11) if and only if there exist constants γ > 0,
ε11, . . . , ε1p, . . . , ε(m(m+1)/2)1, . . . , ε(m(m+1)/2)p satisfying
m(m+1)/2∑
`=1
ε2`r = 1 ; r = 1, . . . , p,(2.15)
such that the point γc ∈ Rk lies on the boundary of the generalized Elfving set R(m(m+1)/2) defined
in (2.13) and has the representation
γc =
p∑
r=1
pr

(m(m+1)/2)∑
`=1
ε`rf˜`(xr)
 ∈ ∂ R(m(m+1)/2).(2.16)
Proof. From assumption (2.14) it follows that u` ∈ {0, 1} and consequently the information
matrix at the experimental condition x = (x1, . . . , xm) is of the form
I(x) =
∑
{`|u`=1}
f˜`(x)f˜`(x)
T .(2.17)
Therefore, the result is a direct consequence of Theorem 3.3 in Dette and Holland-Letz (2009),
which presents a geometric characterization of Elfving type for c-optimal designs in models with
an information matrix of the form (2.17). 
Remark 2.3 If m = 2 observations can be taken for each patient and σ21 = σ
2
2 = σ
2, then
assumption (2.14) is always satisfied, because
V −1i =
1
σ2|Vi|
(
1 −c(xi1, xi2)
−c(xi1, xi2) 1
)
(2.18)
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and |c(xi1, xi2)| ≤ 1.
Remark 2.4 The results can easily be generalized to nonlinear fixed effects models of the form
Yij = η(xij, θ) + ij i = 1, .., n; j = 1, ...,m,(2.19)
where η denotes a (not necessarily linear) function defined on X × Θ. A rather detailed review
and numerous references on optimal designs for nonlinear models can be found in Atkinson and
Haines (1996). In the situation considered in this paper, standard results on nonlinear regression
models show that the covariance matrix of the nonlinear weighted least squares is asymptotically
given by (2.2) where Fi = (f(xi1), ..., f(xim)) ∈ Rk×m and the vector f is given by
f(t) =
∂
∂θ
η(t, θ)(2.20)
Following Chernoff (1953) we assume that a preliminary guess for the unknown parameter θ is
available. In this case the information matrix in (2.10) is well defined and all results of this section
remain correct for the nonlinear model (2.19) using the identification (2.20). In particular locally
c-optimal designs can be characterized by the appropriately modified equivalence Theorem 2.1
and the geometric characterization in Theorem 2.2.
The concept of locally optimal designs has been criticized due to its sensitivity with respect
to misspecification of the unknown parameter. Robust optimal designs could be obtained us-
ing a Bayesian or minimax approach [see e.g. Chaloner and Verdinelli (1995), Dette (1995),
Mu¨ller and Pa´zman (1998)]. A geometric method of constructing Bayesian optimal designs for
one-parameter models and a two-point prior distribution is given by Haines (1995) for the uncor-
related case, but its generalization to models with more parameters, arbitrary prior distributions
or correlated observations seems to be difficult. A generalization of Elfving’s characterization to
these more sophisticated criteria could be derived along the lines of Dette (1996), who considered
the uncorrelated case, i.e. m = 1. However, these investigations are extremely complicated and
will be devoted to future research.
3 Examples
We will demonstrate the application of the geometric characterization of Elfving type in two
examples, a simple 2 parameter fixed effects polynomial model with intrinsically correlated ob-
servations and a nonlinear population model which is commonly used in pharmacokinetics.
3.1 Quadratic regression
As a linear example we consider a two parameter fixed effects quadratic model, where m obser-
vations are taken for each of the n patients, that is
yij = θ1xij + θ2x
2
ij + ij i = 1, ..., n, j = 1, ...,m.(3.1)
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We begin with the case m = 2 and assume that observations corresponding to the same patients
are correlated with covariance function cov(i1, i2) = σ
2c(xi1, xi2) = σ
2λ|xi1−xi2|, i.e.
V −1i = σ
−2
(
1 λ|xi1−xi2|
λ|xi1−xi2| 1
)−1
=
(
v11(xi) v12(xi)
v21(xi) v22(xi)
)
.
In this situation we have f(x) = (x, x2)T and by Remark 2.3 the assumption (2.14) is satisfied,
which yields u` = 1 (` = 1, 2, 3). Consequently, the information matrix can be written as a sum
of m(m+ 1)/2 = 3 terms using the functions
f˜1(xi1, xi2) = h1(xi1, xi2) = f(xi1)
√
|v11(xi)− |v12(xi)||(3.2)
f˜2(xi1, xi2) = h2(xi1, xi2) = f(x2)
√
|v22(xi)− |v12(xi)||(3.3)
f˜3(xi1, xi2) = g12(xi1, xi2) = (f(xi1) + sgn(v12(xi))f(xi2))
√
|v12(xi)|.(3.4)
For the choice of parameters λ = 0.6, σ2 = 0.04 and the design space X = [0, 2] the corresponding
generalized Elfving set R3 defined by (2.13) is depicted in Figure 1. Every pixel in the figure is
induced by a point measurement set x ∈ Xm (m = 2), where the function f˜` and the quantities
ε` in (2.13) are evaluated at a (dense) grid. Both parts of the figure represent the same Elfving
space, but the coloring in the left part corresponds to potential values of the first measurement
x1 of x = (x1, x2), while the coloring in the right part corresponds to the second measurement
x2 (see the legend of Figure 1).
Suppose we want to estimate the linear combination cT θ defined by the vector c = (−1, 1)T ,
which is marked as the red line in Figure 1. The optimal sets of measurements are those which
can be used to construct the point of the intersection of the boundary of the Elfving space with
the line in the direction of the vector c. This representation may require a single point of the
form
p(x) =
m(m+1)/2∑
`=1
`f˜`(x);
m(m+1)/2∑
`=1
2` = 1
or several points p(x1), ..., p(xp) of this type, where p ≤ k and k represent the number of param-
eters in the model (here k = 2). Each point xj = (xj1, ..., xjm) ∈ Xm corresponds to a set of
measurements (in the concrete example we have m = 2) per patient. The weights used in the
convex combination yield the weights of the optimal design, i.e. the proportions of total obser-
vations taken at the corresponding point xj. The actual components xj1 and xj2 of the point
xj can be determined from the coloring of the point p(xj) in the left and right part of Figure 1,
respectively. Thus, we can easily determine the support points graphically. For example, from
Figure 1 we observe that two points, say x1 and x2, are required to represent the boundary point
γc, which are marked by two circles. From the left part of the Figure we obtain that the colour
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of x1 is pink, while the colour of the second point is green, and from the legend in the right
upper part of the figure we obtain the values x11 = 0.0 and x21 = 1.2 for the first components of
x1 and x2, respectively. Similarly, the right part of Figure 1 yields the colours blue and red for
the two points, which yields x12 = 0.8 and x22 = 2.0 for the second components of x1 and x2,
respectively. Therefore the locally c-optimal design advises the experimenter to use two different
individual measurement sets, that is:
ξc =
(
(0.0, 0.8) (1.2, 2.00)
0.48 0.52
)
.(3.5)
This means that 48% of the patients are treated at experimental conditions x11 = 0, x12 = 0.8
and 52% are treated at x21 = 1.2 and x22 = 2.0. Note that in concrete applications the value
of the components can be determined from the exact red/green/blue value of the corresponding
pixel of the points in the representation (2.16) using appropriate graphic software.
Alternatively, we can use the figure to determine any hyperplane H supporting the Elfving space
at the point γc. This plane is defined through a vector d = (d1, d2)
T fulfilling dT z = 1 for all
z ∈ H, (γc)Td = 1 and rTd ≤ 1 for all r ∈ R3. The support points are then given as the solution
of the system of equations
max
1,...,3
3∑
l=1
lf˜l(x1, x2)d = 1,
3∑
i=1
2i = 1
[see the proof of Theorem 3.3 in Dette and Holland-Letz (2009)]. This yields an alternative
derivation of the design (3.5). In both cases the optimality of this design can also be verified by
Theorem 2.1.
We now suppose that m = 3 observations are available for each individual in the quadratic
regression model (3.1). In this case we have m(m+ 1)/2 = 6 and, writing xi = (xi1, xi2, xi3), the
functions f˜l used in the representation (2.10) are given by
f˜1(xi) = h1(xi) = f(xi1)
√|v11(xi)− |v12(xi)| − |v13(xi)||,
f˜2(xi) = h2(xi) = f(xi2)
√|v22(xi)− |v21(xi)| − |v23(xi)||,
f˜3(xi) = h3(xi) = f(xi3)
√|v33(xi)− |v31(xi)| − |v32(xi)||,
f˜4(xi) = g12(xi) = (f(xi1) + sgn(v12(xi))f(xi2))
√|v12(xi)|,
f˜5(xi) = g13(xi) = (f(xi1) + sgn(v13(xi))f(xi3))
√|v13(xi)|,
f˜6(xi) = g23(xi) = (f(xi2) + sgn(v23(xi))f(xi3))
√|v23(xi)|,
where f(x) = (x, x2)T denotes the vector of regression functions and the matrix V −1i =
(vlk(xi))
3
l,k=1 is defined by
V −1i = σ
−2
 1 λ|xi1−xi2| λ|xi1−xi3|λ|xi2−xi1| 1 λ|xi2−xi3|
λ|xi3−xi1| λ|xi3−xi2| 1
−1 .
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Figure 1: The Elfving set R3 defined in (2.13) for a quadratic regression model (3.1) with
two observations per patient. The functions f˜1, f˜2 and f˜3 are given by (3.2), (3.3) and (3.4),
respectively. The vector c is depicted by the red line, while the two black circles denote the points
used in the Elfving representation (2.16).
We can verify that assumption (2.14) is satisfied for this correlation structure (note that this is
not the case for all correlation matrices if m > 2).
The corresponding Elfving set is depicted in Figure 2. As m = 3 here, three subfigures are
needed, each corresponding to one of the components xi = (xi1, xi2, xi3). In this case only one
point is used in the Elfving representation (2.16) and we obtain by a similar reasoning as in the
first part of this example that for c = (−1, 1)T the c-optimal design is given by
ξc =
(
(0.0, 1.0, 2.0)
1
)
.
This means that all individuals have to be treated at experimental conditions 0, 1.0 and 2.0.
11
Figure 2: The Elfving set R6 defined in (2.13) for the quadratic regression model (3.1) with 3
observations per patient. The vector c is depicted by the red line, while the black circle shows the
point used in the Elfving representation (2.16).
3.2 A nonlinear population model
In order to demonstrate the applicability of the methodology to population pharmacokinetic
models, we consider a generic nonlinear random effects model, i.e.
Yij = η(xij, bi) + εij i = 1, . . . , n, j = 1, . . . ,m,(3.6)
where η : X × Rk → R is a known function and the errors εi = (εi1, ..., εim) for each patient are
normally distributed with mean 0 and covariance matrix Wi ∈ Rm×m, i = 1, ..., n. The quantities
b1, . . . bn ∼ N (θ,Ω) denote k-dimensional independent normally distributed random variables
with mean θ and covariance matrix Ω representing the effect of the corresponding subject under
investigation [see Beatty and Piegorsch (1997), Ette et al. (1995), Cayen and Black (1993)]. We
also assume that the random variables b1, . . . , bn and the vector (ε11, . . . , εnm)
T are independent.
Due to the nonlinearity of the model an explicit representation of the corresponding Fisher
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information matrix cannot be derived. Following Retout and Mentre´ (2003) we propose to use a
first-order Taylor expansion to derive an approximation of this matrix. Assuming differentiability
of the regression function we use the expansion
η(x, b) ≈ η(x, θ) + f(x, θ)(b− θ)T ,(3.7)
where
f(x, b) =
∂η(x, b)
∂b
denotes the gradient of the regression function with respect to b. This means that similarly to the
case of fixed effects nonlinear models (see Remark 2.4) the nonlinear model (3.6) is approximated
by the linear model (3.7). For the construction of the design we assume that knowledge about
the parameter θ is available from previous or similar experiments and consider the determination
of locally optimal designs [see Chernoff (1953)]. As a consequence, the covariance matrix of the
nonlinear least squares estimate in the model (3.6) is approximated by replacing the functions
f in model (2.1) with f(x) = f(x, b)|b=θ. The variance of the random vector Yi = (Yi1, ..., Yim)
now includes the variance caused by the random effect and can be approximated by
Var(Yi) = Vi ≈ F Ti ΩFi +Wi i = 1, . . . , n.
Consider for example the simple first order elimination model with two observations for each
subject (bi = (bi1, bi2))
Yij = bi1e
−bi2xij + εij, xij ∈ X = [0, 2], i = 1, ...n, j = 1, 2 ,(3.8)
which is widely used in pharmacokinetics [see e.g. Rowland (1993)]. We assume that the errors
εij are homoscedastic and uncorrelated with variance σ
2 > 0, that is Vi ≈ F Ti ΩFi +σ2Im and for
the parameters we consider the case
θ = (5, 0.8) , Ω = diag(1, 0.1) and σ2 = 0.04.
A straightforward calculation shows that
∂η(x, θ)
∂θ
= (e−θ2x,−θ1xe−θ2x) .
Therefore, we have f(x) = (e−θ2x,−θ1xe−θ2x) and the three functions f˜1, f˜2, f˜3 are defined in a
similar manner as illustrated in Example 1. Moreover, it can be easily checked that assumption
(2.14) is satisfied. The detailed calculations are omitted for the sake of brevity.
The corresponding generalized Elfving set is depicted in Figure 3. If we are interested in the
optimal design for estimating the area under the curve, i.e.
AUC =
∫ ∞
0
θ1e
−θ2xdx =
θ1
θ2
,
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it is easy to see that this corresponds to a locally c-optimal design problem for the vector
c = (1/θ2,−θ1/θ22)T , which is marked as the red line in Figure 3. From this Figure it can be seen
that only one point is needed in the Elfving representation (2.16), and we obtain by a similar
reasoning as in Section 3.1 that the locally c-optimal design for the estimation of the area under
the curve is given by
ξc =
(
(0.0, 2.0)
1
)
.
This means that all patients should be treated under experimental conditions x1 = 0 and x2 = 2.
The optimality of this design can also be verified by Theorem 2.1.
Figure 3: The Elfving space R3 defined in (2.13) for the first order elimination model with 2
observations per patient.
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